[1] 范华南,黄辉,姜庆坤,等.中度和重度牙周炎患者龈下细菌多样性和群落结构分析[J].口腔医学研究,2018,34(8):846-851. [2] Zlotnik A, Yoshie O. The chemokine superfamily revisited [J]. Immunity, 2012, 36(5):705-716. [3] Gojska-Grymajlo A, Zielinski M, Wardowska A, et al. CXCR7+ and CXCR4+ stem cells and neuron specific enolase in acute ischemic stroke patients [J]. Neurochem Int, 2018, 120:134-139. [4] Hosokawa Y, Hosokawa I, Ozaki K, et al. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease [J]. Clin Exp Immunol, 2005, 141(3):467-474. [5] Sun J, Nemoto E, Hong G, et al. Modulation of stromal cell-derived factor 1 alpha (SDF-1alpha) and its receptor CXCR4 in Porphyromonas gingivalis-induced periodontal inflammation [J]. BMC Oral Health, 2016, 17(1):26. [6] Grdovic N, Rajic J, Petrovic SM, et al. Association of CXCL12 gene promoter methylation with periodontitis in patients with diabetes mellitus type 2 [J]. Arch Oral Biol, 2016, 72:124-133. [7] Gu HQ, Zhang ZB, Zhang JW, et al. The role of the SDF-1/ CXCR7 axis on the growth and invasion ability of endometrial cancer cells [J]. Arch Gynecol Obstet, 2017, 295(4):987-995. [8] Guan S, Zhou J. CXCR7 attenuates the TGF-beta-induced endothelial-to-mesenchymal transition and pulmonary fibrosis [J]. Mol Biosyst, 2017, 13(10):2116-2124. [9] Kallifatidis G, Munoz D, Singh RK, et al. beta-Arrestin-2 counters CXCR7-mediated EGFR transactivation and proliferation [J]. Mol Cancer Res, 2016, 14(5):493-503. [10] Pluchino N, Mamillapalli R, Moridi I, et al. G-protein-coupled receptor CXCR7 is overexpressed in human and murine endometriosis [J]. Reprod Sci, 2018, 25(8):1168-1174. [11] Yashiro Y, Nomura Y, Kanazashi M, et al. Function of chemokine (CXC motif) ligand 12 in periodontal ligament fibroblasts [J]. PLoS One, 2014, 9(5):e95676. [12] Kaku M, Kitami M, Rosales Rocabado JM, et al. Recruitment of bone marrow-derived cells to the periodontal ligament via the stromal cell-derived factor-1/C-X-C chemokine receptor type 4 axis [J]. J Periodontal Res, 2017, 52(4):686-694. [13] Zhang M, Qiu L, Zhang Y, et al. CXCL12 enhances angiogenesis through CXCR7 activation in human umbilical vein endothelial cells [J]. Sci Rep, 2017, 7(1):8289. [14] Werner TA, Forster CM, Dizdar L, et al. CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma [J]. Br J Cancer, 2017, 117(12):1837-1845. [15] Yuan CL, Liu ZH, Zou N, et al. Relationship between expression of CXCR7 and NF-kappaB in breast cancer tissue and occurrence of breast cancer and lymphatic metastasis [J]. Saudi J Biol Sci, 2017, 24(8):1767-1770. [16] Zhou Y, Cao HB, Li WJ, et al. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy [J]. Chin J Nat Med, 2018, 16(11):801-810. [17] Ando N, Furuichi Y, Kasai S, et al. Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements [J]. Leuk Res, 2018, 75:36-44. [18] Song ZY, Wang F, Cui SX, et al. CXCR7/CXCR4 heterodimer-induced histone demethylation: a new mechanism of colorectal tumorigenesis [J]. Oncogene, 2019, 38(9):1560-1575. |